NP47924 Cytokine Modulators
Supply of Cytokine Modulators to NHS Scotland.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£1,700,000
Published
19 Mar 2025
Closes
2 Dec 2024
Procurement details
Source
Find a Tender
Region
Scotland
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Etanercept
£11,337,834
Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Delivery: Scotland
Lot 2 Infliximab IV
£5,584,117
Supply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.
Delivery: Scotland
Lot 3 Infliximab SC
£1,364,625
Supply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line.
Delivery: Scotland
Lot 4 Methotrexate syringes (25mg/1 ml concentration)
£57,674
Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Delivery: Scotland
Lot 5 Methotrexate pens (25mg/1ml concentration)
£57,473
Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Delivery: Scotland
Lot 6 Methotrexate pens (50mg/1 ml concentration)
£4,459,687
Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Delivery: Scotland
Lot 7 Methotrexate syringes (50mg/1ml concentration)
£101,754
Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Delivery: Scotland
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.